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Abstract
Background: Cross-talk between integrins and cadherins regulates cell function. We tested the hypothesis that vitronectin
(VN), a multi-functional adhesion molecule present in the extracellular matrix and plasma, regulates vascular permeability
via effects on VE-cadherin, a critical regulator of endothelial cell (EC) adhesion.
Methodology/Principal Findings: Addition of multimeric VN (mult VN) significantly increased VE-cadherin internalization in
human umbilical vein EC (HUVEC) monolayers. This effect was blocked by the anti-aVb3 antibody, pharmacological
inhibition and knockdown of Src kinase. In contrast to mult VN, monomeric VN did not trigger VE-cadherin internalization. In
a modified Miles assay, VN deficiency impaired vascular endothelial growth factor-induced permeability. Furthermore,
ischemia-induced enhancement of vascular permeability, expressed as the ratio of FITC-dextran leakage from the circulation
into the ischemic and non-ischemic hindlimb muscle, was significantly greater in the WT mice than in the Vn
2/2 mice.
Similarly, ischemia-mediated macrophage infiltration was significantly reduced in the Vn
2/2 mice vs. the WT controls. We
evaluated changes in the multimerization of VN in ischemic tissue in a mouse hindlimb ischemia model. VN plays a
previously unrecognized role in regulating endothelial permeability via conformational- and integrin-dependent effects on
VE-cadherin trafficking.
Conclusion/Significance: These results have important implications for the regulation of endothelial function and
angiogenesis by VN under normal and pathological conditions.
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Introduction
Extracellular matrix (ECM) glycoproteins participate in many
physiological and pathological processes, including ischemic
vascular diseases, inflammation, tumor growth and metastasis.
Endothelial cell (EC)-ECM interactions play a key role in cellular
functions by binding multiple cell surface receptors and are critical
for the activation of cell signal transduction pathways. One of the
components of the ECM, vitronectin (VN), is a multifunctional
glycoprotein that is in an inactive state in the plasma; however, the
VN incorporated into the ECM is predominately multimeric, with
exposed binding sites that interact with integrins and cell surface
receptors that regulate cell adhesion and cellular motility. Levels of
VN are increased in patients with various cardiovascular diseases,
tumor growth and metastasis. Although mice with a genetic
deletion of VN develop normal vasculature during embryogenesis,
abnormal localization of VN is expected to lead to a conforma-
tional change that results in compromised vasculature, including
pathological angiogenesis [1,2,3,4]. The conformational change in
VN followed by tissue injury or other pathological conditions are
the key events in the regulation of cell adhesion [2,3,5].
Angiogenesis encompasses cell proliferation, migration, and
differentiation. Loosening of cell-to-cell contacts is the key initial
event that causes normally quiescent ECs to initiate angiogenesis.
Cell-to-cell adhesion is mainly achieved by VE-cadherin, which is
a critical EC-specific adhesion molecule. Activation of avb3b y
integrin antagonists disrupt VE-cadherin and enhance vascular
permeability [6,7]. Recent studies have demonstrated that the
binding of integrins to ECM components disrupts VE-cadherin
regulated cell-to-cell adhesion by regulating the inactivation of Src
[8,9]. These studies suggest that cell-ECM interactions participate
in the regulation of cell-to-cell contacts.
Previous studies have demonstrated that the avb3 integrin-VN
interaction plays an important role in potentiating VEGF signaling
by interacting with the integrin-VEGFR-2-Src signaling pathway
[10,11,12]. VN has been shown to be involved in promoting
transendothelial migration by interacting with leukocyte Mac-1
during adhesion and extravasation [13,14]. Although ECM-
derived VN multimerizes in response to various types of tissue
injury, and this transition involves functional changes in the vessel,
such as angiogenesis, the role of VN in VE-cadherin-mediated
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the present study, we evaluated whether VN is implicated in the
regulation of cell-to-cell contacts and vascular permeability. We
found that VN redistributes VE-cadherin by promoting internal-
ization of VE-cadherin and increases vascular permeability. The
process is inhibited by blocking the avb3 integrin and the Src
kinase signaling pathway. Furthermore, in a mouse hindlimb
ischemia model, we demonstrated that ischemia induced the
multimerization of VN in ischemic tissues, and this multimeriza-
tion was linked to ischemia-mediated vascular leakage.
Results
VN induces VE-cadherin internalization
VE-cadherin is a major junctional molecule that mediates cell–
to-cell adhesion [15,16]. There is evidence that binding of the
integrins-ECM components perturbs VE-cadherin-mediated ad-
herens junctions [8,9]. To examine the role of VN in VE-
cadherin-mediated cell-to-cell contacts, we investigated the impact
of VN on VE-cadherin distribution. In confluent monolayers of
untreated HUVECs, cell surfaces displayed intact VE-cadherin
staining (Figure 1A-a). In contrast, continuous VE-cadherin
staining in cell-to-cell contacts was disrupted by mult VN after
4 hrs of treatment (Figure 1A-b), whereas fibronectin and type I
Figure 1. Mult VN promotes VE-cadherin internalization. (A) HUVECs were treated with mult VN (10 mg/mL). Confocal microscopy showed
continuous and organized VE-cadherin staining, which is normally observed in ECs at cell-cell junctions (A-a). VN stimulation resulted in a
disorganized pattern of VE-cadherin distribution at the membrane and led to intracellular accumulation of VE-cadherin (A-b); (B). To further
determine whether cell surface-derived VE-cadherin was internalized into intracellular compartments, cells were prepared without acid washing and
analyzed using confocal microscopy as described in Methods. A time-dependent internalization of VE-cadherin was observed (upper panels, B-a-d).
Pretreatment with LM 609 (LM) and su6656 (su) prevented VN-mediated VE-cadherin internalization (B-e, f, lower panels). VE-cadherin internalization
was not observed after treatment with mono VN (10 mg/mL)(B-h). VEGF (50 ng/mL) as a positive control (B-g). (C). Cells were prepared by acid
washing and analyzed using confocal microscopy and cell surface VE-antibody was removed with a low pH acid wash. VN treatment increased the
intracellular accumulation of VE-cadherin internalized from the cell surface (C-b, c) relative to no treatment (C-a). Nuclei are stained with DAPI. The
scale bars represent 10 mm. Arrows: cell surface; Arrowhead: intracellular accumulation. (D). HUVEC monolayers were treated with VN at the indicated
dose. Cells were lysed using RIPA buffer for western blotting analysis of total VE-cadherin. (E). Cells were treated with trypsin/EDTA, pelleted and lysed
with RIPA for western blotting analysis of intracellular VE-cadherin. (F). HUVECs were transfected with Src siRNA or scrambled siRNA (con siRNA). The
efficiency of Src protein expression knock-down was analyzed using immunoblot (left panel). Cells were treated with trypsin/EDTA, pelleted and lysed
with RIPA for western blotting analysis of intracellular VE-cadherin (right panel). b-actin was used as a loading control.
doi:10.1371/journal.pone.0037195.g001
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cadherin (data not shown). Furthermore, in a time-response curve,
mult VN promoted the rapid intracellular accumulation of VE-
cadherin (Figure 1B-a-d). The internalization of VE-cadherin
induced by mult VN could be prevented by pretreatment with
LM609, an avb3 integrin antibody, and by su6656, a Src family
kinase inhibitor (Figure 1B-e, f). Here, VEGF was used as a
positive control (Figure 1B-g), as it has been observed to promote
VE-cadherin internalization [15,17]. Importantly, mono VN
(10 mg/mL) had no effect on VE-cadherin (Figure 1B-h), which
indicated that mult VN is critical for VE-cadherin internalization
at cell-to-cell contacts.
To directly observe intracellular VE-cadherin staining, a
specific immunofluorescence protocol for fixation and sample
preparation was used in the visualization [15,18]. The cells were
acid washed to remove the cell surface VE-cadherin bound
antibodies. Increased accumulation of intracellular VE-cadherin
was observed with VN treatment compared to the control
(Figure 1C-b-c). Internalization of the VE-cadherin caused by
mult VN was also demonstrated using western blot analysis. Mult
VN did not have an effect on the VE-cadherin expression in total
cell lysates from HUVEC monolayers at the indicated concentra-
tions (Figure 1D). To further distinguish the accumulation of the
cell surface and intracellular VE-cadherin, HUVECs were
trypsinized to remove cell surface cadherin. Increased VE-
cadherin internalization in the intracellular compartment was
observed with trypsin detachment (Figure 1E), and the internal-
ization was inhibited with pretreatment with LM609 and su6656.
Furthermore, the role of Src in VE-cadherin internalization was
confirmed using Src siRNA (Figure 1F and Supplemental Figure
S2). These results indicated that VN promotes VE-cadherin
internalization and may be involved in the activation of the avb3
integrin-Src signaling pathway.
Figure 2. Mult VN activates Src and increases vascular permeability. (A). HUVECs were pretreated with LM609 (LM) (25 mg/mL) for 30 min
before mult or mono VN (10 mg/mL) treatment. Phosphorylation of Src (PY418) was determined by western blotting analysis(upper and middle
panel); Mult VN stimulates tyrosine phosphorylation of VE-cadherin in HUVECs. Cells were incubated with mult VN (10 mg/mL) for 60 min or
VEGF(50 ng/mL) for 30 min. Cell extracts were subjected to immunoprecipitation with antibody against VE-cadherin. Precipitated protein was
analyzed by Western blot using anti-phosphotyrosine antibody. The same blot was then subsequently reprobed with antibody to VE-cadherin. (B).
Mult VN, not mono VN increases vascular permeability in vitro using the permeability assay. HUVEC monolayers were pretreated with LM609 (LM)
(25 mg/mL) and su6656 (su) (1 mM) for 30 min before mult or mono VN (10 mg/mL) treatment. Permeability is represented by relative fluorescence
units measured by the flux of FITC-Dextran across the monolayer of HUVECs. Immunoglobulin G (IgG) and dimethyl sulfoxide (DMSO) vehicle were
used as the controls. (C). Knockdown of Src with siRNA blocked VN-induced vascular permeability. The results are expressed as the mean 6 SEM. *
p,0.05 vs. control.
doi:10.1371/journal.pone.0037195.g002
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vascular permeability
Activation of Src induces ECM-mediated disruption of VE-
cadherin at cell-cell adherents [8,9]. Therefore, we investigated if
such a complex may be involved in internalization of VE-cadherin
and the increase of vascular permeability with VN treatment. We
compared the ability of mult VN and with mono VN to activate
Src kinase by examining the phosphorylation status of Src. As
shown in Figure 2A (upper and middle panel), phosphorylation of
Src in HUVECs was observed with mult VN but not with mono
VN, and its activation was inhibited by LM609, which suggests
that the mult VN-induced activation of Src correlates with the
binding of avb3 integrin. These findings suggested that mult VN
may regulate VE-cadherin internalization through binding of the
avb3 integrin to Src, leading to Src activation. We also examined
the effect of mult VN on the phosphorylation of VE-cadherin, as
shown in Figure 2A (lower panel), mult VN stimulated the tyrosine
phosphorylation of VE-cadherin, indicating that the phosphory-
lation of VE-cadherin by mult VN maybe involved in the
internalization of VE-cadherin. We next performed an in vitro
permeability assay. As shown in Figure 2B, mult VN-induced
permeability of the EC monolayer was inhibited by pretreatment
with LM609 and su6655. The role of Src in VN-mediated vascular
permeability was further confirmed with the knockdown of Src by
siRNA (Figure 2C).
VN deficiency reduced vascular permeability
To gain insight into the role of VN in ischemia-mediated
permeability in vivo, we examined vascular integrity in a mouse
hindlimb ischemia model. Whole-mount staining revealed that
one day after FITC-dextran injection of mice, there was an higher
level of perivascular leakage and diffuse deposition of FITC in the
ischemic gastrocnemius muscles of the WT mice compared with
that of the Vn
2/2 mice. PECAM-1 immunostaining was
performed to visualize capillary formation (Figure 3A). The
fluorescent intensities of cross-sections that were assessed by
confocal microscopy were significantly greater in the WT mice
than in the Vn
2/2 mice (1.64610
560.09 vs. 1.05610
560.15/um
2
ischemic/non-ischemic; n=6; p=0.02; Figure 3B). Ultrastructur-
al examination of the ischemic gastrocnemius muscles revealed
Figure 3. Vn
2/2 mice impaired vascular permeability. (A). Whole-mount FITC-dextran angiograms in the WT and the Vn
2/2 mice at day 7 in a
mouse hindlimb ischemia model. Dextran leakage was more marked in the wild-type mice (upper panels, arrows) than in the Vn
2/2 mice in ischemic
gastrocnemius muscles. Capillaries were visualized by red Cy3-conjugated PECAM-1 antibodies. (B). Fluorescent intensities of cross-sections of non-
ischemic (R2) and ischemic muscles (R1) were measured, and the R1/R2 ratio was used to assess the level of extravasation of FITC-dextran.
Permeability was reduced in the gastrocnemius muscles in the Vn
2/2 mice compared to the WT mice (n=6, p,0.05). (C). Electron microscopy of
capillaries in the ischemic gastrocnemius muscles showed a diffuse and irregular basement membrane without distinct boundaries in WT mice in
contrast to those of the Vn
2/2 mice (upper panel, scale in 2 mm; lower panel is higher magnification. (D). The miles assay was performed with 50 ng/
mL of VEGF and saline in the right and left ears, respectively, in the WT and Vn
2/2 mice. Evan’s blue dye extravasation was quantified with a
spectrophotometer. The results are expressed as the mean 6 SEM. * p,0.05. (n=6 for each strain).
doi:10.1371/journal.pone.0037195.g003
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was found in the WT mice but not in the Vn
2/2 mice (Figure 3C).
These changes were associated with EC swelling and increased
endothelial permeability, as described previously [19,20]. Further-
more, we used the Miles assay to measure vascular leakage in the
skin of Vn
2/2 and WT mice. As shown in Figure 3D, VEGF-
mediated hyperpermeability was significantly impaired in the Vn
2/
2 mice compared with that in the WT mice. Taken together, these
results indicated that VN increases vascular permeability in vivo.
Increased multimerization of VN after ischemia
To determine whether the increased permeability is associated
with VN deposition and conformational change after ischemia, we
examined VN expression in response to ischemic injury in a mouse
hindlimb model. As shown in Figure 4A, VN gene expression in
ischemic gastrocnemius muscles was determined by RT-PCR.
Ischemia significantly increased the expression of VN in ischemic
gastrocnemius muscles at day 7 compared with non-ischemic
gastrocnemius muscles in WT mice (n=9/group). Western blot
analysis demonstrated that VN protein was markedly increased in
ischemic gastrocnemius muscles at day 7 after ischemic injury
(Figure 4B). Because mult VN is the active form of this protein and
is the form that interacts with the ECM, we next examined the
conformational changes of VN in ischemic tissues. As shown in
Figure 4C, under reducing conditions, VN in ischemic gastroc-
nemius muscles was detected as a ,75 kDa protein, and no high
molecular weight forms were detected. Ischemia-induced VN was
further analyzed under nonreducing conditions, and the intensities
of the multimer bands in GM VN were remarkably increased with
ischemia, which is characteristic of mult VN [21,22]. Vn
2/2 mice
showed no detectable VN (data not shown). These observations
suggest that multimerization of VN was induced by ischemia.
To determine the role of VN in ischemia-induced angiogenesis,
we measured capillary density by staining ischemic tissue with
anti-PECAM-1 antibody. Supplemental Figure S1 shows that
PECAM-1-positive capillary density was significantly reduced in
the ischemic tissue of Vn
2/2 mice compared with WT mice.
VN deficiency suppress inflammatory cells infiltration
To determine whether VN-induced vascular permeability could
be related to inflammatory cell infiltration in ischemia, we
examined the infiltration of macrophages in ischemic muscles.
Infiltration of macrophages into the ischemic hind limb was
determined by immunostaining with the anti-Mac3 antibody. No
macrophages were detected in nonischemic muscles (Figure 5A).
Ischemia induced an increase in infiltration of macrophages in the
WT mice relative to the Vn
2/2 mice at day 7 post femoral ligation
(50.7068.58 vs. 23.3162.32 macrophages/mm
2,n = 6 ,
p,0.05)(Figure 5B). Next, we examined whether leukocyte
infiltration was reduced in another model of inflammatory
Figure 4. Increased multimerization of VN in the tissue after ischemia. (A) and (B). RT-PCR and western blot analysis of VN from the
gastrocnemius muscles indicated that ischemia induced VN expression in the WT mice (n=6). R: Right leg; L: Left leg, NI: Nonischemic; I: Ischemic. (C).
An equal amount of gastrocnemius muscle lysates (each 20 mg) were subjected to SDS-PAGE under nonreducing and reducing conditions and were
analyzed by immunoblotting. The mobility of molecular weight standards for SDS-PAGE is indicated. Data are presented as fold changes (n=9;
*p,0.05 vs. control).
doi:10.1371/journal.pone.0037195.g004
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2/2 mice. The number of leukocytes recruited into
the peritoneal cavity was counted at 72 hours after injection of
thioglycollate, a stimulatory agent to induce non-infectious
peritoneal inflammation for elicitation of macrophages. The
number of resident cells in the peritoneal cavity was unchanged
between WT and Vn
2/2 mice, however, thioglycollate-elicited
cells were significantly reduced in Vn
2/2 mice compared with that
in WT mice (Figure 5C) (6.6060.77 Vs. 12.3360.56, n=5,
p,0.01). FACS analysis showed that the number of CD45-FITC-
and PI-positive cells in peripheral blood was unchanged between
WT and Vn
2/2 mice after hindlimb ischemia (Figure 5D).
Further, we assessed in vitro transendthelial migration (TEM) of
murine mononuclear cells. The results showed that Vn
2/2
mononuclear cells had significantly impaired TEM in both
untreated and TNFa-treated groups as compared to WT
mononuclear cells (Figure 5E). Thus, VN deficiency was associated
with reduced transendothelial migration of leukocytes.
Discussion
The binding of VN to EC surfaces is mediated by the u-PA
receptor and integrins [23,24]. It is well established that VE-
cadherin is critical for the stability of cell-to-cell junctions. At least
three molecular pathways are involved in regulating this process: i)
degradation of VE-cadherin at cell-to-cell contacts, ii) tyrosine
phosphorylation of VE-cadherin [25], and iii) internalization of
VE-cadherin at cell-to-cell contacts [15,18]. Here, we show that
mult VN increases vascular permeability by promoting internal-
ization of VE-cadherin at cell-to-cell contacts in a Src-dependent
mechanism.
The role of integrin-ECM interaction in controlling vascular
permeability has been studied in different ways in vitro and in vivo
[6,26,27]. In normal physiological conditions, the application of
RGD peptides or avb3 antagonists had an inhibitory effect on
vascular permeability, which indicated that binding of the avb3
integrin-VN maintains normal endothelial barrier function.
Importantly, tissue injury or activation of inflammatory cells
usually results in the release of enzymes capable of exposing
cryptic RGD fragments from ECM components, including
Figure 5. Vn
2/2 mice reduced inflammatory cells infiltration. (A) Recruitment of macrophages in response to ischemia as determined by the
Mac-3 antibody. Representative images of macrophages in nonischemic and ischemic muscles in the WT and Vn
2/2 mice on day 7 after femoral
artery ligation are shown. (B) The number of Mac3-positive cells was quantified. Data are the mean 6 SEM from 10 fields per section (3 sections/
mouse and n=6 for each strain). *p,0.05. (C) The number of thioglycollate-elicited mouse peritoneal macrophages was quantified. The results are
expressed as the means 6 SEM. * p,0.05. (n=6 for each strain). (D) The number of CD45-FITC- and PI- positive cells in peripheral blood was analyzed
by flow cytometry after hindlimb ischemia by staining with CD45-FITC and PI (Propidium iodide). The results are expressed as the means 6 SEM. *
p.0.05. (n=6 for each strain). (E). Transendthelial migration of murine mononuclear cells with TNFa of ECs. Murine aortic ECs were grown to
confluency on cell culture inserts. ECs were then treated with 20 ng/mL TNFa for 4 hrs. Murine mononuclear cells were added on the endothelial
layer for 4 hrs. Migrated cells were stained and measured by OD 450 nm according to the assay instructions. The results are expressed as the mean 6
SEM. *p,0.05 vs. WT; **p,0.05 vs. control. Data shown are representative of three independent experiments.
doi:10.1371/journal.pone.0037195.g005
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VN stimulation resulted in the rapid internalization of VE-
cadherin at cell-to-cell junctions. These findings indicated that VN
can disrupt cell-to-cell contacts by promoting the internalization of
VE-cadherin and can cause the loss of VE-cadherin from the cell
surface. Our report supports the observations that matricryptic
peptide fragments of VN have vascular permeability effects, as
previously discussed in the vascular responses to tissue injury
[3,29].
We found that VN deficiency impaired vascular permeability in
the ischemic hindlimb, which suggests that VN is necessary for
ischemia-induced hyperpermeability after arterial occlusion.
However, the role of VN in normal physiological regulation is
somewhat controversial. Previously, Wu et al. found that integrin
binding to VN maintains the barrier function in isolated porcine
coronary venules [26], furthermore, treatment of the venules with
VN did not significantly alter basal permeability, which provides
information that is relevant to the physiological mechanisms
controlling microvascular exchange. We speculate that physiolog-
ical regulation of VN is largely related to an inactive mono form.
In contrast, tissue injury or other pathological alterations could
cause VN conformational change, which may promote vascular
leakage, as observed in our hindlimb ischemia model.
We demonstrated that VN induced the activation of Src
through avb3 integrin. Both pharmacological inhibition and Src
siRNA significantly inhibit VN-induced internalization of VE-
cadherin and endothelial vascular permeability. EC adhesion to
provisional ECM components, such as fibronectin and collagen I,
has been shown to disrupt VE-cadherin at the cell-to-cell contacts
in a Src dependent mechanism [8,9]. Previous work has
demonstrated that the binding of avb3 integrin to VN potentiates
the activation of Src kinase, which is linked to EC migration
[10,11,12]. This mechanism correlates with the binding of Src to
the cytoplasmic domain of both the a and b subunits [29]. In the
present study, we confirmed that VN promotes Src phosphory-
lation in ECs, and the avb3 integrin is required for the activation
of Src. In addition to binding to integrins on the cell surface, VN
also interacts with uPAR. This binding is important in controlling
extracellular proteolysis and cellular adhesion. The mechanism by
which Src mediates VE-cadherin internalization remains unclear;
however, it is interesting to note that the internalization of VE-
cadherin is largely dependent on binding of avb3 integrin by VN,
which in turn, triggers the crosstalk between the avb3 integrin and
Src.
We have investigated the synthesis and conformational changes
of VN after femoral ligation in the plasma and tissue of ischemic
mice. In this study, we showed that VN was highly upregulated in
ischemic muscles. Most importantly, conformational changes in
VN were induced by ischemia. The increased local changes in the
multimerization of VN, either produced locally or derived from
vascular leakage of circulating VN, is likely attributable to an
increase in vascular permeability during ischemia.
The transendothelial migration of leukocytes has been shown to
be enhanced by vasoactive substances that disrupt VE-cadherin at
endothelial junctions and increase vascular permeability
[30,31,32]. In fact, recent studies have shown that VN contributes
to neutrophil chemotaxis [13,14]. In the present study, the number
of infiltrated leukocytes was lower in the Vn
2/2 mice than in the
WT mice. These results suggest that VN-mediated VE-cadherin
localization seems to be important for leukocyte migration across
the endothelium.
Our findings suggest that the binding of to avb3 integrin mult
VN promotes the internalization of VE-cadherin via the activation
of Src activation. The observed increased in permeability induced
by mult VN is consistent with internalization of VE-cadherin and
its disappearance from cell-to-cell contacts. Multimerization of VN
plays an important role in ischemia-induced angiogenesis in vivo.
The mechanism is likely related to inflammatory cell infiltration by
VN-mediated VE-cadherin at cell-to-cell contacts and vascular
permeability.
Materials and Methods
Reagents
Human multimeric VN (Mult VN) and human monomeric VN
(Mono VN) were obtained from Molecular Innovations (South-
field, MI). Human multimeric VN (Mult VN) was prepared from
fresh human plasma using urea as a denaturant. Human
recombinant vascular endothelial growth factor (VEGF) was
purchased from R&D Systems. The inhibitor of the Src family
kinase su6656 was obtained from Calbiochem (La Jolla, CA).
LM609 (anti-avb3 integrin antibody) was purchased from
Chemicon. The following antibodies were used: rabbit anti-VE-
cadherin (Sigma), rabbit anti-c-Src, and rabbit anti-phosphor-Tyr-
418-Src (Biosource, QCB, Camarillo, CA).
Cell Culture
Human umbilical vein endothelial cells (HUVECs, Cascade
Biologics) were grown in Medium 200 (Cascade Biologics)
supplemented with LSGS. Mouse EC were isolated from mouse
aortas and grown in culture as described previously [33]. Mouse
mononuclear cells were isolated from peripheral blood according
to the manufacturer’s protocol by using Histopaque (Sigma)
centrifugation. Cells were resuspended in DMEM plus 0.25% BSA
for transmigration experiments.
Immunofluorescence and VE-cadherin Internalization
assay
Cells were grown on coverslips and were treated with VN. Cells
were fixed in cold methanol followed by extraction in 0.5% Triton
X-100. Distribution of VE-cadherin was detected using rabbit
anti-human VE-cadherin (Santa Cruz Biotechnology, Inc.). The
secondary antibodies used were goat ant-rabbit IgG AlexaFluor
546-conjugated antibody (Molecular Probes, Invitrogen). Images
were analyzed with a Zeiss LSM 510 2-photon confocal system.
For immunofluorescence studies of the internalization of VE-
cadherin, cells were treated using a protocol adapted from
previous publications [15,18]. Briefly, cells were incubated with
rabbit anti-human VE-cadherin for 1 hour. Cells were then
treated with VN. To remove the cell-surface bound antibodies
while retaining the internalized antibodies, cells were acid washed
for 30 min in phosphate-buffered saline (PBS), pH 2.7, containing
25 mM glycine and 3% bovine serum albumin. The cells were
rinsed, fixed, and processed for immunofluorescence as described
above. All pictures are representative of 3 independent experi-
ments.
Miles vascular permeability assay
The miles assay was performed as previously described [34].
Briefly, mice were administered Evans blue dye, and VEGF
(300 ng in 15 ml) or saline was then injected subcutaneously into
the dorsal surface of the right and left ears, respectively. After
30 minutes, mice were euthanized and their ears removed, oven-
dried at 55uC, and weighed. The Evans blue dye was then
extracted from the ears using 500 ml of formamide for 24 hours at
55uC, and the absorbance of extracted dye was measured at
630 nm.
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Age-matched C57BL/6J mice were purchased from Jackson
Labs. C57BL/6J-congenic VN-deficient (Vn
2/2) mice were a gift
from Dr. David Ginsburg, University of Michigan [35]. All animal
care and experimental procedures complied with the Guide for the
Care and Use of Laboratory Animals published by the US National
Institutes of Health (NIH publication no. 85-23, revised 1996),
and experiments were approved by the Office of Animal
Resources of the University of Missouri. Mice were anaesthetized
with sodium pentobarbital (60 mg/kg body weight, intraperitone-
ally) or isoflurane (5%, by inhalation) and a single subcutaneous
dose of buprenorphine hydrochloride (0.1 mg/kg) for analgesia.
Additional sodium pentobarbital (12 mg/kg body weight) or 5%
isoflurane was given as needed to maintain anaesthesia. The depth
of anaesthesia was evaluated by pinching the pedal withdrawal
reflex. Mice were euthanized by cervical dislocation at the end of
the experiment while still anaesthetized. Mice were subjected to
unilateral hindlimb ischemia as previously described [36]. Mouse
hindlimb protein samples were immunoblotted according to the
method of Laemmli under reducing or nonreducing conditions
[37,38] and the RT-PCR analysis [39] for mouse VN. In some
experiments, mouse hindlimbs were used for immunostaining.
Fluorescent dextran injection
To assess the ischemia-mediated permeability of microvessels,
mice were subjected to femoral artery ligation for 7 days. A 250 ml
of 0.25 mg/mL solution of FITC-conjugated dextran (75 kDa,
Sigma) was injected into the tail vein 1 day before sarcrifice. All
gastrocnemius muscles were fixed for whole mounting and
immunostaining using cy3-conjugated mouse PECAM-1 antibody
(Sigma). The amount of FITC-dextran in the gastrocnemius
muscles was determined with confocal microscopy. The ratio of
the FITC intensities in the ischemic to the intensities in the non-
ischemic muscle was calculated for each mouse.
siRNA
The Src siRNA target sequence was CTCCATGTGCGTC-
CATATTTA. Cells were transfected with 0.5 mg of siRNA
duplexes using the RNAi Starter Kit (Qiagen). Transfected cells
were incubated in culture medium for 48 hr and were harvested
for detection of Src by western blot. A second set of cells was used
for the in vitro permeability assay.
RT-PCR
Total RNA was extracted from the cells using TRIzol reagent
(Invitrogen) and digested with DNase I (Ambion). Reverse
transcriptase (RT)-polymerase chain reaction (PCR) was per-
formed using SuperScript 1-step RT-PCR (Invitrogen). Mouse
VN and 18 S mRNA levels were determined by reverse
transcription–polymerase chain reaction (RT-PCR). The band
intensity of the RT-PCR products was quantified using the
Fluochem 8800 Imaging system (Aloha Innotech).
Immunoblotting
HUVECs were harvested in RIPA buffer (Sigma), and the total
protein was subjected to 4–20% SDS-polyacrylamide gel. Trans-
ferred membrane was probed with the rabbit anti-VE-cadherin
antibodies (Santa Cruz Biotechnology) as described. In some
experiments, HUVECs were rinsed and were incubated in trypsin-
EDTA at 37uC for 5 min to remove cell surface VE-cadherin as
previously described [15,32]. Trypsin was inactivated using
normal growth medium and the cells were recovered by
centrifugation. Cell pellets were lysed for immunoblotting. For
control, parallel cultures were harvested in RIPA buffer without
trypsinization.
In vitro permeability assay
Endothelial permeability was analyzed in vitro by diffusing of
75 kDa fluorescein isothiocyanate (FITC)-dextran (Sigma) through
the endothelial monolayer [18]. HUVECs were grown to
confluence on transwell inserts (Costar, Cambridge, MA, USA).
The cells were pretreated with the Src inhibitor, su6655 (1 mM),
and the avb3 integrin antibody, LM609 (25 mg/mL) for 30 min-
utes. VN (10 mg/mL) was added to medium for 4 hours. Medium
containing 75 kDa FITC-dextran was then loaded in the upper
compartment of the transwell. The amount of FITC-dextran that
diffused through the endothelial monolayer into the lower
compartment was measured using a microplate reader (Molecular
Devices, Sunnyvale, CA).
In vitro leukocytes transmigration assay
Migration assays were performed with QCM
TM leukocyte
transendothelial migration assay kit (Millipore, USA) using the
supplier’s protocol. Briey, murine aortic EC were grown to
conuence on Matrigel-coated Transwell filters and treated with
TNF-a overnight. The lower chamber was filled with assay
medium (DMEM plus 0.25% BSA) plus 5 ng/ml IL-8 as
chemoattractant. EC were washed twice with assay medium and
subsequently incubated with 1610
5 mononuclear cells at 37uC,
10% CO2 for 4 h. 20 ml of WST-1 solution was added to each
well. The plate was incubated for three hours at 37uC and 5%
CO2. Conversion of WST-1 solution was measured by absorbance
at 450 nm.
FACS Analysis
To quantify inflammatory cells in peripheral blood, WT and
Vn
2/2 mice (n=4 each) were subjected to hindlimb ischemia.
Peripheral blood was suspended in PBS containing 1% BSA and
was subjected to flow cytometry. Inflammatory cells were analyzed
using anti-mouse CD45 antibody and propidium iodide. Cells
were finally fixed with 1% paraformaldehyde (Ph 7.5) in PBS and
analyzed by flow cytometry.
Transmission electron microscopy
Each harvested gastrocnemius muscle was fixed with 3%
glutaraldehyde. After postfixation with 2% osmium tetroxide,
the tissues were dehydrated in a graded series of ethanol and were
embedded in Epon 812. The ultra-thin sections were cut, stained
with uranyl acetate, and examined under a JEOL 1400 EX
transmission electron microscope (Nippon Denshi Ltd., Tokyo,
Japan) at 80 kV.
Immunostaining
Gastrocnemius muscle sections (10 mm) were mounted on glass
slides. Immunostaining was performed as described previously
[18]. Slides were blocked with BSA and were incubated with
rabbit IgG raised against mouse PECAM-1 (Santa Cruz Biotech-
nology). Negative controls were incubated without the primary
antibody. The secondary antibody was biotinylated goat IgG
raised against rabbit IgG (Santa Cruz Biotechnology). Washed
slides were incubated with Vectastain Elite ABC reagent (Vector
Laboratories), developed using DAB substrate (Vector Laborato-
ries), and counterstained with hematoxylin. Images were captured
with a 406objective lens using an Olympus (DP70) microscope.
Vessel density was calculated as vessel number per field and
plotted as mean 6 SEM.
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Macrophages were obtained by flushing the peritoneal cavity
with PBS 4 days after intraperitoneal injection with 1 mL of a 3%
thioglycollate solution (Difco Laboratories, Sparks, MD). Collected
elicited-macrophages from peritoneum were counted by micros-
copy in WT and Vn
2/2 mice.
Statistical Analysis. Data are expressed as the mean 6 SEM
from experiments that were performed at least in triplicate.
Groups were compared using Student’s 2-tailed t test.
Supporting Information
Figure S1 Impaired capillary formation in Vn
2/2 mice.
(A). Anti-PECAM-1 staining was performed to examine capillary
density in ischemic and nonischemic gastrocnemius muscles.
Representative capillary density was enhanced in ischemic tissue in
WT mice, but not Vn
2/2 mice. (B). Capillary density was
expressed as the number of PECAM-1-positive cells per high
power filed (6400). Data are presented as fold changes. n=6 for
each stain. *p,0.05 vs. Vn
2/2. Scale bar denotes 5 mm.
(TIF)
Figure S2 Knock down of Src blocks mult VN-induced
VE-cadherin internalization. HUVECs were transfected with
Src siRNA or con siRNA. Cells were treated with mult VN
(10 mg/mL) for 4 hrs. Cells were prepared for anti-VE-cadherin
staining and analyzed using confocal microscopy as described in
Methods. Nuclei are stained with DAPI. The scale bars represent
10 mm. Arrows: cell surface; Arrowhead: intracellular accumula-
tion. Representative confocal fluorescence microscopy images of 3
experiments are shown.
(TIF)
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